Germany's Dermapharm Looks To Future With Arkopharma As 2022 Sales Rise
Executive Summary
Dermapharm has high hopes for 2023 as its acquisition of Arkopharma means the firm is now the number-one and number-three player respectively in the French and Spanish supplements markets.